Page last updated: 2024-12-10

citroxanthin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5281246
CHEBI ID7037
SCHEMBL ID39732
MeSH IDM0042135

Synonyms (16)

Synonym
LMPR01070277
C08605
citroxanthin
mutatochrome
515-06-0
4,4,7a-trimethyl-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-6,11,15-trimethyl-17-(2,6,6-trimethylcyclohexen-1-yl)heptadeca-2,4,6,8,10,12,14,16-octaen-2-yl]-2,5,6,7-tetrahydro-1-benzofuran
SCHEMBL39732
CHEBI:7037
15678-54-3
5,8-epoxy-5,8-dihydro-.beta.,.beta.-carotene
.beta.,.beta.-carotene, 5,8-epoxy-5,8-dihydro-
mutatochrome, all-trans-
5,8-epoxy-5,8-dihydro-b,b-carotene
flavacin?
beta-carotene 5,8-epoxide
Q15425813

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"There are significant differences among patients treated with warfarin in the dosage volumes necessary to reach an optimum therapeutic effect."( [Pharmacogenetics of warfarin].
Kessler, P, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
xanthophyllA subclass of carotenoids consisting of the oxygenated carotenes.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (30.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.26 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (18.18%)6.00%
Case Studies1 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other8 (72.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]